A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

Clinical trial NCT03596866 · COMPLETED

Trial details

NCT number: NCT03596866
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

ALK+ Advanced NSCLC

Start date: 2019-04-19
Primary completion: 2024-02-27
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.